Wellgistics Health Faces Nasdaq Delisting Risk Over Bid Price Compliance
Reuters
Dec 16
Wellgistics Health Faces Nasdaq Delisting Risk Over Bid Price Compliance
Wellgistics Health Inc. has received a notice from the Nasdaq Stock Market stating that its common stock has failed to meet the minimum closing bid price requirement of $1.00 per share for 30 consecutive business days, as mandated by Nasdaq Listing Rule 5550(a)(2). The company has until June 8, 2026, to regain compliance with this rule. If it does not do so, it may be eligible for an additional 180-day compliance period, provided it meets other listing requirements and notifies Nasdaq of its plan to address the deficiency, potentially through a reverse stock split. Failure to comply could result in the company's stock being delisted from the Nasdaq Capital Market.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027830), on December 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.